In autumn 1993, AAMI/ST/WG 63, Sterilization Residuals Working Group undertook the task of studying factors involved in determining the amount of residual ethylene oxide in medical devices after sterilization and developing a protocol for controlling the relevant variables. The protocol was evaluated by conducting a round robin study consisting of 8 participating laboratories from around the country. Results of this round robin study demonstrated the range over which results may vary despite controls placed on the time and temperature at which determinations were conducted. The data from the study suggest that small, random variations in technique during short sample extraction times can lead to variability in the results. Variables such as initial water temperature, oven temperature, weighing of sample, and length of extraction should be carefully controlled. Inherent variations in the material composition of similar devices are possible contributing factors. The efforts of this working group and the subsequent evaluation and discussion of its findings are presented.
G iven the diversity of medical devices sterilized with ethylene oxide (EO) and the potential for toxic effects on patients exposed to residues of EO in these devices, the U.S. Food and Drug Administration (FDA) and industry have focused on the accurate and precise determination of these residues, and have set exposure limits. A number of studies have been reported on the determination of residual EO in medical devices (1) (2) (3) (4) (5) . The adoption of an international standard for EO residues in medical devices (ANSI/AAMI/ISO 10993-7:1995, Biological Evaluation of Medical Devices-Part 7: Ethylene Oxide Sterilization Residuals) has brought attention to the concept of determining residual EO. The standard prescribes testing a device in a manner that represents its intended use regarding duration and temperature of patient exposure and relevant fluid characteristics such as static containment (e.g., plastic containers and syringes) or fluid flow (e.g., IV tubing). This approach, intended to simulate the use of the device, is the primary method for determining EO residuals outlined in Annex A of AAMI TIR No. . This latter document provides guidance for implementing ANSI/AAMI/ISO 10993-7:1995 for American industry and regulatory bodies. For such methods to be effective, all variables that influence the test outcome must be understood and controlled.
AAMI/ST/WG 63, Sterilization Residuals Working Group undertook the task of studying these factors and developing a protocol for conducting simulated use testing. A decision was made to select 60 mL polypropylene syringes as surrogates, representing static containment devices constructed of 2 or more substances (e.g., plastic and rubber) commonly used in manufacturing medical devices. These syringes were exposed to EO and subsequently aerated in discrete batches before each part of the study was conducted. This was done to eliminate EO exposure process variables, attempting to create, as far as possible, a standard EO exposure sample.
Test Methodology
Deionized water was the prescribed extraction fluid for simulated use testing. Its selection was based on the work of Kroes et al. who studied EO oxide extraction and stability in water and blood (personal communication to AAMI committee, 1985) . This study was the reference in previous ANSI EO residual testing standards and the current ANSI/AAMI/ISO 10993-7:1995 standard for the recommendation to use deionized water. To minimize potential errors caused by thermal effects during extractions, the water used was preheated to the same temperature as that used in the extraction incubation. Syringes were weighed and then filled by removing the tip cap, placing the tip in a container of preheated water, and pulling the plunger back to the 50 mL mark. Excess air, if any, was expelled so that no significant air pockets were present. The tip cap was replaced tightly to seal the tip opening, and the syringe was re-weighed to determine the gross weight of the fill water.
To retard additional aeration facilitated by air exchanges over the samples during incubation, the weighing procedure was conducted as rapidly as possible, one syringe at a time, and each syringe was then tightly wrapped in aluminum foil. Following extraction, the contents of each syringe were mixed thoroughly to eliminate potential concentration gradients, and aliquots were placed in 2 mL gas chromatography autosampler vials with Teflon-lined septa so that the amount of head space was no more than 200 µL per vial. Samples were analyzed within 24 h of extraction, and vials were stored at 2-8°C in an inverted position. The fill volumes for each syringe were calculated by dividing the net weight of water for each device by the density at the preheated water/incubation temperature.
The method for determining the amount of EO in the extracts was adopted from one of the referee methods (6, 7) . Specifically, the method calls for direct injection of the extracts into a gas chromatograph configured as follows: Column: 6 ft × 2 mm id glass; packing: 3% Carbowax 20M on 80/100 mesh Chromosorb 101; oven: Isothermal at 60-75°C; injector temperature: 200°C; detector: flame ionization detector at 200°C; carrier gas: Heat 35 mL/min; injection volume: 3 µL.
The system was calibrated for each part of the study by using at least 3 working standards ranging from 0.5 to 50 µg EO/mL. Standards were prepared by volumetrically diluting an EO standard stock solution (Supelco, Bellefonte, PA) with deionized water. Duplicate injections of each extract and standard were made, and an electronic integrator was used to determine peak areas. Extracts from unexposed syringes were analyzed to demonstrate the absence of sample indigenous substances that could interfere with the analysis of EO. As a final precaution, extracts from exposed syringes were analyzed for ethylene chlorohydrin and ethylene glycol to ensure that conversion of EO to those compounds would not influence results. All preliminary studies as well as exposures and aeration of sample syringes were conducted by Sterilization Technical Services, Rush, NY, from October 1993 to September 1994.
Effect Of Temperature On Extraction Rates
The first study was designed to assess the effect of temperature on the EO extraction rate. Fifteen exposed syringes were individually weighed; and 3 each were prepared as previously described, and then incubated at 23, 36, 45, 56, and 66°C for 30 min (Table 1) .
Syringe Extraction Temperature Study
Despite some overlap, the data clearly demonstrated a trend for increase in the rate of EO extraction with increase in extraction temperature (Table 1) any simulated-use protocol, temperature fluctuations must be rigorously controlled.
Effect Of Incubation Time On Extraction Rates
Because most simulated use situations involve the amount of EO released at either ambient room temperature (20-25°C) or body temperature (37°C), the change in release rate of EO as a function of time was evaluated at these 2 temperature conditions. Five sets consisting of 3 EO-exposed syringes each were prepared for extraction at 25°C, and 5 additional sets were prepared for extraction at 37°C. After 0.5, 2.0, 6.0, 24.0, and 48.0 h, one set of 3 was removed from each incubator, and the extracts were taken for analysis. The results of this study are shown in Tables 2 and 3 and in Figure 1 .
Syringe Extraction Time Studies at 25 and 37°C
The data in Tables 2 and 3 further confirm the effect of extraction temperature on the amount of EO extracted. Figure 1 demonstrates a general trend for variations in extraction rate as a function of time and shows that the EO desorption rate at both temperatures follows first-order kinetics. The desorption rate at 37°C is approximately 2-3 times faster than that at 24°C during the first 6 h, approaching 0 after 24 h of extraction. The amount of EO extracted from 24 to 48 h is relatively small (<7% of the EO extracted during the first 24 h). In comparison, the changes in EO desorption rate at 25°C between 0.5 and 48 h are less, and the amount of EO extracted from 24 to 48 h is proportionately greater (about 50% of the EO extracted during the first 24 h). The trend is important to the understanding of factors that affect simulated use extraction, showing clearly that the greatest variations (hence, the largest errors) associated with temperature differences are likely to occur during the first 24 h. Thus, the variability between samples at each temperature group of the first study where the extraction time was set at 30 min becomes understandable. In those cases, random temperature variations of the environ- ment surrounding each sample in an incubator would have a greater impact on the amount of EO extracted during the short extraction period. These data also support the expectation that, as devices with similar residue burdens reach the exhaustion point for residue extraction, the rates of extraction will merge along with the total amount of residue, and the effect of extraction temperature becomes less relevant. Hence, the variability in results from short-term simulated use determinations would be greater than those for exhaustive extractions performed on the same product.
Protocol Development
A protocol for conducting simulated use studies was developed, benefited by the clarity provided by the pilot studies.
This protocol was intended to encompass all aspects of testing, including such details as water quality specifications, incubator temperature tolerances, and the order of sample preparation and extraction. For practical reasons, the extraction temperature of 37°C was selected, and time intervals of 0.5 and 24 h were selected to evaluate the "worst case" repeatability of the results. Six syringes were tested at each time interval, for a total of 12 syringes.
Because the test of validity of any protocol is in the universality of its application, a round robin evaluation was planned with a number of volunteer laboratories around the United States, and the protocol was focused on distributing samples to these participants. All syringes used were from a single manufacturing lot and a single EO exposure/aeration batch. Each syringe was individually sealed within a foil pouch, stored, and shipped on dry ice in identical insulated containers via overnight priority service for receipt the following day by 10 a.m. local time. Each participant was provided with 15 packaged syringes from which only 12 were to be used. Start and stop times were synchronized to ensure that the amount of elapsed time was consistent from lab to lab regardless of time zones. The amount of temperature equilibration time for the packaged syringes was set to allow frozen containers to reach room temperature. EO standard stock solutions were provided from the same commercial source to all participants, with working standard dilutions clearly specified. As controls, 50 mL volumes of water used to fill the sample syringes were stored in glass containers and incubated along with samples for subsequent analysis. The start time for gas chromatographic analysis following extraction was standardized, but the order of sample and standard injections was purposely randomized to minimize analytical system biases. The gas chromatography operational parameters were also standardized to conform to the conditions previously used, and minimum system suitability requirements were established.
Round Robin Results
Before involving a larger number of laboratories, the protocol was evaluated by conducting a pilot round robin study with only 3 of the volunteer laboratories. The results of this preliminary study conducted in September 1994 are shown in Table 4 .
The percentage of relative standard deviations for the interlaboratory pilot study were as good as or better than those obtained in the preliminary studies conducted in a single laboratory. Therefore, it was decided that the larger round robin should proceed with only minor operational changes and clarifications to the protocol. The results of the full-scale round robin study conducted in October 1995 with 8 participating laboratories are shown in Table 5 .
Pilot and Full-Scale Interlaboratory Simulated Use Round Robin Test Results and Statistical Evaluation
Round robin tests are undertaken for a variety of reasons among which is the accumulation of data to be used to determine the precision and accuracy of a new or modified test procedure or method. A major concern of quality assurance is how well the laboratory's results agree with those of other laboratories conducting the same test. As a result, the full-scale round robin results were statistically analyzed. Tables 6 and 7 show the intra-and interlaboratory variations, respectively.
Intra-and Interlaboratory Variations and Paired Sample t-Test
Intralaboratory variation, the variation within each laboratory, was computed on the basis of 6 observations for each lab at 0.5 and 24 h. Interlaboratory variation, the variation among laboratories, was computed on the basis of 48 observations combined at 0.5 and 24 h. A t-test comparing the data obtained by each pair of laboratories was performed to evaluate agreement at an alpha value of 0.05 (Table 8 ). The adjusted t value for alpha = 0.05 of 28 observations is 0.05/28 = 0.0017. The t value for alpha = 0.00089 (two-sided tests of 10 degrees of freedom) is 4.22. Therefore, t values <4.22 indicate statistical agreement at the 95% confidence level. With the exception of lab 2 vs lab 5 (t = 4.326) at 0.5 h, no significant statistical differences in the interlaboratory data were found. 
Discussion
In ANSI/AAMI/ISO 10993-7:1995, allowable limits for EO were established as not more than 20 mg EO within 24 h and 60 mg within 30 days, expressed as dose to a patient. Large devices with significant polymeric content (extracorporeal blood purification or oxygenator systems) can easily have a total residue content in excess of these amounts. Moreover, in clinical situations involving therapy using such devices over several days, it is critical to establish that the rate of administration (i.e., the rate of desorption) of EO will not lead to an excessive dose. Clearly, this is more a question of simulating product use than of total EO residual burden in the device.
Based on results of this study, the current practice of simulated use extraction methodology can be evaluated. First, the data relating to the rates of extraction for the syringes demonstrate that EO desorbs from a given polymeric material (or combination of constituent polymers) at a rate that is a function of temperature. Because desorption is not instantaneous, the total residual EO burden in a device does not necessarily reflect the EO dose to a patient exposed to that device. The accurate determination of such dosages is critical for development of reliable risk assessment data used by toxicologists, epidemiologists, medical device manufacturers, and regulatory bodies.
With appropriate control, simulated use extractions can provide valuable information in these instances. Temperature tolerances must be set as tightly as practical, particularly at elevated temperatures, so as not to affect the rate of extraction for the selected duration. Because 37°C is likely to be the temperature used for such extractions, it is strongly recommended that incubators that have been temperature-mapped and continuously monitored be used. An additional concern is the uncontrolled variable of air exchange over the sample as it extracts. Bourillet and Pradeau (personal communication) acknowledged the effect of uncontrolled aeration on precision during a European multilaboratory study in which sets of syringes were aerated and extracted under ambient (non-uniform) conditions for 4-24 h. The use of aluminum foil or other nonpermeable barrier materials to minimize air space over the device needs to be considered during a simulated use study. A third concern is the variability among devices themselves. During this study, and in the Bourillet and Pradeau study, it was noted that even a device as simple as a syringe may vary in weight and in the proportion of the constituent materials (i.e., the mass of the plunger tip relative to the mass of the polymeric body). Differences in the ratios of the materials affect not only the EO content of each device, but also the rate of desorption. Therefore, a well-constructed, simulated use protocol will use enough samples to account for device-to-device variability.
Finally, extraction times must be selected judiciously to obtain results sufficiently precise to maintain a reasonable level of assurance. This effect is discernable in Table 6 , which compares the precision of all participating laboratories for each of the 2 extraction periods. The range of precision values expressed as % RSD was smaller (12-37%) for 24-h extractions than for 0.5-h extractions (8-42%). These data are consistent with those of an earlier study, suggesting that variations are most likely to be larger when shorter extraction periods (hours vs days) are used at elevated temperatures (37°C), especially when extraction has not been exhaustive. 
Conclusion
The full-scale round robin study shows that variability among results from all participant laboratories is not statistically significant. Polypropylene syringes extracted for a longer period of time (24 h) yielded results having greater precision than those extracted for a shorter period (0.5 h). This can be seen in the percent relative standard deviation (Table 7 ). Figure 1 shows that EO desorbs at 37°C at a much higher rate at the initial (shorter) extraction stage (0.5-6 h) than at later stages (>24 h). EO desorbs linearly initially, then starts to reach a plateau after 24 h. Thus, small variations in extraction techniques at short extraction times can lead to greater variability in the results. Variables such as initial water temperature, oven temperature, weighing of sample, and length of extraction should be carefully controlled.
Because the rate of EO desorption is likely to vary significantly from one polymer type to another, studies evaluating devices composed of different materials (i.e., latex catheters, polyvinyl chloride tubing) should be conducted. Further work evaluating static fluid extraction versus mobile fluid path extraction for devices such as IV sets, dialysis elements, and blood separators is also strongly indicated.
